Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06461338 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 17, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 3 of 3 sites
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Feb 2025 to Jul 2026
    • Start date changed from estimate of Aug 2024 to Aug 15, 2024
    • Site details revised at 3 of 3 sites
    v3
  3. Start date: Jun 2024 to Aug 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This multicentre, randomized controlled trial evaluates the effect and safety of integrating acupuncture with immunotherapeutic sensitization in treating NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four cycles of standard ICIs combined with chemotherapy.
Trial Details
NCT Number NCT06461338
Lead Sponsor Guangzhou University of Traditional Chinese Medicine
Collaborators: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine
Conditions
(from sponsor)		 Non-small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov